Skip to content

SPACES: Digital Innovation Meets Contemporary Art at Phillips

By API User

A Selling Exhibition of Multidisciplinary Works by 8 Global Artists LONDON, ENGLAND / ACCESSWIRE / September 25, 2024 / HOFA Gallery and PhillipsX announce the launch of ‘SPACES’, the inaugural selling exhibition in HOFA’s new curated digital realities series; which brings together leading voices in the intersection of technology and art. The selling exhibition, set … Continued

GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis

By API User

ANKARA, TURKEY / ACCESSWIRE / September 25, 2024 / GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the positive results of its Phase 2 clinical trial evaluating the safety and efficacy of its investigational drug, GN-037 topical cream, in treating mild to moderate plaque psoriasis. The findings were presented at Amsterdam’s European Academy … Continued

Standard Foods Partners With Rimini Street to Fund AI-Powered Predictive Data Analytics Project

By API User

Rimini Support™ for SAP enables manufacturer to reallocate resources towards supply chain improvements, driving stronger profitability and operational efficiency LAS VEGAS–BUSINESS WIRE– Rimini Street, Inc. (Nasdaq: RMNI), a global provider of end-to-end enterprise software support, products and services, the leading third-party support provider for Oracle and SAP software, and an AWS partner, today announced that … Continued

Alcoa Schedules Third Quarter 2024 Earnings Release and Conference Call

By API User

PITTSBURGH–BUSINESS WIRE– Alcoa Corporation (NYSE: AA; ASX: AAI) plans to announce its third quarter 2024 financial results on Wednesday, October 16, 2024, after the close of trading on the New York Stock Exchange. Alcoa will host a conference call to discuss the third quarter financial results on October 16, 2024, at 5:00 p.m. EDT (October … Continued

Medidata Extends Its Commitment to the Patient Experience with the Launch of Patient Payments

By API User

New solution accelerates payments to patients participating in a clinical trial, improving experience and access NEW YORK–BUSINESS WIRE– Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced the launch of Medidata Patient Payments, a new solution that streamlines trial-related stipends and reimbursements for patients participating … Continued

TreviPay Expands Dealer Management Offering with Advanced API Integrations

By API User

Enhanced integration capability for commercial equipment dealerswill enable seamless, convenient onboarding and line-item transaction details for fleet programs OVERLAND PARK, Kan.–BUSINESS WIRE– TreviPay, the most-trusted B2B payments and invoicing network, today announces enhancements for dealer management systems for commercial equipment dealers servicing fleets. In addition to providing a smooth onboarding and integration process, TreviPay’s advanced … Continued

Allonnia and Mining3 Partner to Expand Collaboration in the Mining Industry and Accelerate Innovations to Market

By API User

BOSTON–BUSINESS WIRE– Allonnia, the bio-ingenuity company dedicated to extracting value where others see waste, today announced their partnership with Mining3, a world-leading research organization. This collaboration aims to accelerate the development and scaling of Allonnia’s sustainable mining innovations by working closely with Mining3’s global network of mining companies and researchers. This press release features multimedia. … Continued

Honcho Introduces AI-Enhanced Tools for Simplified Website Building

By API User

SYDNEY, Sept. 25, 2024 (GLOBE NEWSWIRE) — Honcho has launched new artificial intelligence (AI) tools to simplify creating and launching business websites. This new suite of enhanced tools aims to make website building even more accessible to startup and small business owners who lack technical, creative, or marketing skills. Photo by afotostock “Our goal with … Continued

Fujirebio Submits FDA Regulatory Filing for Lumipulse® G pTau 217/ß-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test as an Aid to Identify Patients With Amyloid Pathology Associated With Alzheimer’s Disease

By API User

—Expected to Be First Commercially-Available Blood-Based In-Vitro Diagnostic for Patients Being Assessed for Alzheimer’s Disease in the U.S.— —Availability of Accurate, Assessable, Blood-Based Diagnostic Tests Will Aid in Development and Availability of More Effective Interventions for Alzheimer’s Disease— MALVERN, Pa. & TOKYO–BUSINESS WIRE– Fujirebio today announced that its wholly-owned subsidiary Fujirebio Diagnostics, Inc. has filed … Continued